نتائج البحث - "Glucagon-Like Peptide-1 Receptor"

21

دورية أكاديمية

Impact of baseline characteristics and beta‐cell function on the efficacy and safety of subcutaneous once‐weekly semaglutide: A patient‐level, pooled analysis of the SUSTAIN 1‐5 trials.

المؤلفون: Aroda, Vanita R.¹ (AUTHOR) varoda@bwh.harvard.edu, Capehorn, Matthew S.² (AUTHOR), Chaykin, Louis³ (AUTHOR), Frias, Juan P.⁴ (AUTHOR), Lausvig, Nanna L.⁵ (AUTHOR), Macura, Stanislava⁵ (AUTHOR), Lüdemann, Jörg⁶ (AUTHOR), Madsbad, Sten⁷ (AUTHOR), Rosenstock, Julio⁸ (AUTHOR), Tabak, Omur⁹ (AUTHOR), Tadayon, Sayeh⁵ (AUTHOR), Bain, Stephen C.¹⁰ (AUTHOR)

المصدر: Diabetes, Obesity & Metabolism. Mar2020, Vol. 22 Issue 3, p303-314. 12p.

مصطلحات موضوعية: *GLUCAGON-like peptide-1 receptor, *CHARACTERISTIC functions, *GLUCAGON-like peptide-1 agonists, *TYPE 2 diabetes, *PANCREATIC beta cells, *GLYCEMIC control, *MEDICATION safety

22

دورية أكاديمية

المؤلفون: Fadini, Gian Paolo¹ gianpaolo.fadini@unipd.it, Sciannameo, Veronica², Franzetti, Ivano^3,4, Bottigliengo, Daniele², D'Angelo, Paola^5,6, Vinci, Carmela^7,8, Berchialla, Paola⁹, Arena, Salvatore^10,11, Buzzetti, Raffaella^12,13, Avogaro, Angelo¹, Consoli, Agostino¹⁴, Formoso, Gloria¹⁴, Grossi, Giovanni¹⁵, Pucci, Achiropita¹⁶, Sesti, Giorgio¹⁷, Andreozzi, Francesco¹⁷, Capobianco, Giuseppe¹⁸, Gatti, Adriano¹⁹, Bonadonna, Riccardo²⁰, Zavaroni, Ivana²⁰

المصدر: Diabetes, Obesity & Metabolism. Aug2019, Vol. 21 Issue 8, p1886-1894. 9p.

مصطلحات موضوعية: *GLUCAGON-like peptide-1 receptor, *GLUCAGON-like peptide-1 agonists, *SYSTOLIC blood pressure, *PROPENSITY score matching, *TYPE 2 diabetes, *BODY weight

مصطلحات جغرافية: ITALY

People: DARWIN, Charles, 1809-1882

23

دورية أكاديمية

Navigating the "MACE" in Cardiovascular Outcomes Trials and decoding the relevance of Atherosclerotic Cardiovascular Disease benefits versus Heart Failure benefits.

المؤلفون: Hupfeld, Christopher^1,2, Mudaliar, Sunder^1,2 smudaliar@vapop.ucsd.edu

المصدر: Diabetes, Obesity & Metabolism. Aug2019, Vol. 21 Issue 8, p1780-1789. 10p.

مصطلحات موضوعية: *CARDIOVASCULAR diseases, *GLUCAGON-like peptide-1 receptor, *HEART failure, *GLUCAGON-like peptide-1 agonists, *TYPE 2 diabetes, *DRUG-eluting stents

24

دورية أكاديمية

Preventing all‐cause hospitalizations in type 2 diabetes with sodium‐glucose cotransporter‐2 inhibitors and glucagon‐like peptide‐1 receptor agonists: A narrative review and proposed clinical approach.

المؤلفون: Schechter, Meir, Fischer, Matan, Mosenzon, Ofri

المصدر: Diabetes, Obesity & Metabolism; Jun2022, Vol. 24 Issue 6, p969-982, 14p

مصطلحات موضوعية: GLUCAGON-like peptide-1 agonists, SODIUM-glucose cotransporters, TYPE 2 diabetes, GLUCAGON-like peptide-1 receptor, SODIUM-glucose cotransporter 2 inhibitors, HOSPITAL care, RANDOMIZED controlled trials

25

دورية أكاديمية

Comparable COVID‐19 outcomes with current use of GLP‐1 receptor agonists, DPP‐4 inhibitors or SGLT‐2 inhibitors among patients with diabetes who tested positive for SARS‐CoV‐2.

المؤلفون: Israelsen, Simone Bastrup, Pottegård, Anton, Sandholdt, Håkon, Madsbad, Sten, Thomsen, Reimar Wernich, Benfield, Thomas

المصدر: Diabetes, Obesity & Metabolism; Jun2021, Vol. 23 Issue 6, p1397-1401, 5p

مصطلحات موضوعية: COVID-19, SARS-CoV-2, GLUCAGON-like peptide-1 agonists, SODIUM-glucose cotransporters, PEOPLE with diabetes, GLUCAGON-like peptide-1 receptor, TREATMENT effectiveness

26

دورية أكاديمية

Treatment persistence in patients with type 2 diabetes treated with glucagon‐like peptide‐1 receptor agonists in clinical practice in Sweden.

المؤلفون: Svensson, Ann‐Marie, Toll, Anders, Lebrec, Jeremie, Miftaraj, Mervete, Franzén, Stefan, Eliasson, Björn

المصدر: Diabetes, Obesity & Metabolism; Mar2021, Vol. 23 Issue 3, p720-729, 10p

مصطلحات موضوعية: GLUCAGON-like peptide-1 agonists, TYPE 2 diabetes, GLUCAGON-like peptide-1 receptor, TREATMENT effectiveness

مصطلحات جغرافية: SWEDEN

27

دورية أكاديمية

The novel dual glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 (GLP‐1) receptor agonist tirzepatide transiently delays gastric emptying similarly to selective long‐acting GLP‐1 receptor agonists

المؤلفون: Urva, Shweta, Coskun, Tamer, Loghin, Corina, Cui, Xuewei, Beebe, Emily, O'Farrell, Libbey, Briere, Daniel A., Benson, Charles, Nauck, Michael A., Haupt, Axel

المصدر: Diabetes, Obesity & Metabolism; Oct2020, Vol. 22 Issue 10, p1886-1891, 6p

مصطلحات موضوعية: GLUCAGON-like peptide-1 agonists, TYPE 2 diabetes, GLUCAGON-like peptide-1 receptor, GASTRIC emptying, PLACEBOS

28

دورية أكاديمية

Pharmacokinetic and dose‐finding studies on efpeglenatide in patients with type 2 diabetes.

المؤلفون: Yoon, Kun‐Ho, Kang, Jahoon, Kwon, Se Chang, Trautmann, Michael E., Hompesch, Marcus, Stewart, John, Sorli, Christopher H.

المصدر: Diabetes, Obesity & Metabolism; Aug2020, Vol. 22 Issue 8, p1292-1301, 10p

مصطلحات موضوعية: TYPE 2 diabetes, PHARMACOKINETICS, BLOOD sugar, GLUCAGON-like peptide-1 agonists, SUBCUTANEOUS injections, GLUCAGON-like peptide-1 receptor

29

دورية أكاديمية

Oral semaglutide for type 2 diabetes: A systematic review and meta‐analysis.

المؤلفون: Avgerinos, Ioannis, Michailidis, Theodoros, Liakos, Aris, Karagiannis, Thomas, Matthews, David R., Tsapas, Apostolos, Bekiari, Eleni

المصدر: Diabetes, Obesity & Metabolism; Mar2020, Vol. 22 Issue 3, p335-345, 11p

مصطلحات موضوعية: TYPE 2 diabetes, DRUG-eluting stents, SYSTOLIC blood pressure, GLUCAGON-like peptide-1 agonists, WEIGHT loss, BODY weight, GLUCAGON-like peptide-1 receptor, META-analysis

30

دورية أكاديمية

Trends in antidiabetic drug utilization and expenditure in Denmark: A 22‐year nationwide study.

المؤلفون: Bang, Camilla, Mortensen, Martin B., Lauridsen, Kasper G., Bruun, Jens M.

المصدر: Diabetes, Obesity & Metabolism; Feb2020, Vol. 22 Issue 2, p167-172, 6p

مصطلحات موضوعية: DRUG utilization, EXENATIDE, GLUCAGON-like peptide-1 receptor, GLUCAGON-like peptide-1 agonists, TYPE 2 diabetes, COST accounting, DRUG prices

مصطلحات جغرافية: DENMARK

تنقيح النتائج